Eliminating tuberculosis one neighborhood at a time

American Journal of Public Health

Volumn 103, Issue 7, 2013, Pages 1292-1300

  Cegielski, J Peter ^a   Griffith, David E ^b   McGaha, Paul K ^c   Wolfgang, Melanie ^a   Robinson, Celia B ^c   Clark, Patricia A ^b   Hassell, Willis L ^b   Robison, Valerie A ^a   Walker, Kerfoot P ^d   Wallace, Charles ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF TEXAS AT TYLER   (United States)

^c TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^d Smith County Appraisal District   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CHILD; COMPARATIVE STUDY; DEMOGRAPHY; DISEASE ERADICATION; FEMALE; GEOGRAPHIC MAPPING; HISPANIC; HUMAN; INCIDENCE; LUNG TUBERCULOSIS; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; RISK FACTOR; STATISTICS; THORAX RADIOGRAPHY; TUBERCULIN TEST; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANTITUBERCULAR AGENTS; CHILD; DISEASE ERADICATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GEOGRAPHIC MAPPING; HISPANIC AMERICANS; HUMANS; INCIDENCE; ISONIAZID; MALE; MASS SCREENING; MIDDLE AGED; RADIOGRAPHY, THORACIC; RESIDENCE CHARACTERISTICS; RISK FACTORS; TEXAS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

MLCS; MLOWN;

EID: 84879025931     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2012.300781     Document Type: Article

References (18)

1. Bennett DE, Courval JM, Onorato I, et al. Prevalence of tuberculosis infection in the United States population: The National Health and Nutrition Examination Survey, 1999-2000. Am J Respir Crit Care Med. 2008;177(3):348-355. (Pubitemid 351198380)
2. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161(4 pt 2):S221-S247.
3. Reported Tuberculosis in the United States, 2009. Atlanta, GA: Centers for Disease Control and Prevention; October 2010.
4. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Bibl Tuberc. 1970;26:28-106.
5. Centers for Disease Control and Prevention. The use of preventive therapy for tuberculous infection in the United States: recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR Recomm Rep. 1990;39(RR-8):6-12.
6. Comstock GW, Woolpert SF. Preventive therapy. In: Kubica GP, Wayne LG, eds. The Mycobacteria: A Sourcebook. New York, NY: Marcel Dekker Inc; 1984:1071-1082.
7. International Union Against Tuberculosis, Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60(4):555-564.
8. Horsburgh CR Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350(20):2060-2067.
9. Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep. 1995;44(RR-11):19-34.
10. Geiter L, ed. Ending Neglect: The Elimination of Tuberculosis in the United States. 1st ed. Washington, DC: National Academy Press; 2000.
11. Centers for Disease Control and Prevention. Prevention and control of tuberculosis in US communities with at-risk minority populations: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep. 1992;41(RR-5):1-11.
12. Moonan PK, Bayona M, Quitugua TN, et al. Using GIS technology to identify areas of tuberculosis transmission and incidence. Int J Health Geogr. 2004;3(1):23.
13. Moonan PK, Oppong J, Sahbazian B, et al. What is the outcome of targeted tuberculosis screening based on universal genotyping and location? Am J Respir Crit Care Med. 2006;174(5):599-604. (Pubitemid 44330554)
14. American Thoracic Society. Control of tuberculosis in the United States. Am Rev Respir Dis. 1992;146 (6):1623-1633.
15. Brown RE, Miller B, Taylor WR, et al. Health-care expenditures for tuberculosis in the United States. Arch Intern Med. 1995;155(15):1595-1600.
16. Taylor Z, Marks SM, Rios Burrows NM, Weis SE, Stricof RL, Miller B. Causes and costs of hospitalization of tuberculosis patients in the United States. Int J Tuberc Lung Dis. 2000;4(10):931-939.
17. Marks SM, Taylor Z, Miller BI. Tuberculosis prevention versus hospitalization: taxpayers save with prevention. J Health Care Poor Underserved. 2002;13(3):392-401.
18. Horsburgh CR, Goldberg S, Bethel J, et al. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest. 2010;137(2):401-409.